Johnson Matthey (LON:JMAT) Stock Price Expected to Rise, Citigroup Analyst Says

Johnson Matthey (LON:JMAT) had its price objective lifted by Citigroup from GBX 1,800 to GBX 2,100 in a report issued on Tuesday, Marketbeat.com reports. The firm presently has a “neutral” rating on the stock.

Several other equities research analysts have also weighed in on JMAT. Deutsche Bank Aktiengesellschaft increased their target price on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a “buy” rating in a report on Thursday, October 9th. Jefferies Financial Group upped their price objective on shares of Johnson Matthey from GBX 2,200 to GBX 2,420 and gave the company a “buy” rating in a research report on Tuesday, October 14th. Finally, Berenberg Bank lifted their target price on Johnson Matthey from GBX 1,950 to GBX 2,100 and gave the stock a “hold” rating in a report on Thursday, October 9th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, Johnson Matthey has a consensus rating of “Moderate Buy” and a consensus price target of GBX 2,230.

Johnson Matthey Price Performance

JMAT opened at GBX 2,100 on Tuesday. The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The stock has a market capitalization of £3.52 billion, a P/E ratio of 9.94, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The company’s 50 day simple moving average is GBX 1,969.94 and its 200-day simple moving average is GBX 1,718.24. Johnson Matthey has a one year low of GBX 1,131 and a one year high of GBX 2,188.

Insiders Place Their Bets

In other Johnson Matthey news, insider Andrew Cosslett acquired 10,495 shares of the company’s stock in a transaction that occurred on Tuesday, August 26th. The stock was acquired at an average cost of GBX 1,896 per share, for a total transaction of £198,985.20. Insiders have bought a total of 10,521 shares of company stock worth $19,948,290 over the last three months. Corporate insiders own 0.50% of the company’s stock.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.